According to Carisma Therapeutics's latest financial reports the company's current EPS (TTM) is -2,96ย โฌ. In 2021 the company made an earnings per share (EPS) of -0,98ย โฌ a decrease over its 2020 EPS that were of -0,68ย โฌ.